MGL-3196

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Product Details
Company Profile

Min.Order :0
Purity: 95%

Keywords

CHEMBL3261331 UNII-RE0V0T1ES0

Quick Details

Appearance:
Application:potential treatment for non-alcoholic steatohepatitis (NASH) and dyslipidemias
PackAge:250 mg
ProductionCapacity:
Storage:
Transportation:

Superiority:

We provide customized and high-quality MGL-3196 product for your project.

Details:

MGL-3196 is a first-in-class, orally available, once-daily and liver-directed thyroid hormone receptor (THR) beta-selective agonist. Studies suggest that MGL-3196 has an attractive, differentiated profile as a potential treatment for non-alcoholic steatohepatitis (NASH) and dyslipidemias.

View All